Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling-Reference-Cited by-同舟云学术

Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling

Published:2016-07 Issue: Volume:160 Page:40-48
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Liu Ping,He Kun,Song Hongjiao,Ma Zhufeng,Yin Weihai,Xu Lisa X.

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference41 articles.

1. Breast cancer statistics, 2011;DeSantis;CA Cancer J. Clin.,2011

2. Iron and cancer: more ore to be mined;Torti;Nat. Rev. Cancer,2013

3. Novel chelators for cancer treatment: where are we now?;Merlot;Antioxid. Redox Signal.,2013

4. A probable risk factor of female breast cancer: study on benign and malignant breast tissue samples;Rehman;Biol. Trace Elem. Res.,2014

5. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer;Cui;Cancer Epidemiol. Biomarkers Prev.,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis;Journal of Cellular and Molecular Medicine;2023-12-22

2. Macrophages as a Potential Immunotherapeutic Target in Solid Cancers;Vaccines;2022-12-26

3. Targeting ferroptosis, the achilles’ heel of breast cancer: A review;Frontiers in Pharmacology;2022-11-16

4. Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor;Frontiers in Oncology;2022-07-28

5. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia;BioMed Research International;2022-07-06